An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination. - BRABANTS, E.; HEYNS, K.; SMET, S. DE; DEVREKER, P.; INGELS, J.; CABOOTER, N. DE; DEBACKER, V.; DULLAERS, M.; VAN MEERBEECK, J.P.; VANDEKERCKHOVE, B.; VERMAELEN, K.Y. (Cytotherapy (Elsevier Inc.), 2018)